Screener
Intellia Therapeutics NTLA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's asset turnover?
- Intellia Therapeutics (NTLA) reported asset turnover of 0.1× in Q2 2026.
- How has Intellia Therapeutics's asset turnover changed year-over-year?
- Intellia Therapeutics's asset turnover increased by 34.0% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Intellia Therapeutics's asset turnover?
- Over 5 years (2020 to 2025), Intellia Therapeutics's asset turnover has grown at a -10.3% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Intellia Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude